Siloxane nanoprobes for labeling and dual modality imaging of neural stem cells

Addington, Caroline P.; Cusick, Alex; Shankar, Rohini Vidya; Agarwal, Shubhangi; Stabenfeldt, Sarah E.; Kodibagkar, Vikram D.

doi:10.1007/s10439-015-1514-1

Back to Previous Page

Siloxane nanoprobes for labeling and dual modality imaging of neural stem cells

Published Date:

Nov 23 2015

Publisher's site:

http://dx.doi.org/10.1007/s10439-015-1514-1

Source:

Ann Biomed Eng. 44(3):816-827.

[PDF-958.35 KB]

Details:

Alternative Title:

Ann Biomed Eng

Personal Author:

Addington, Caroline P. ; Cusick, Alex ; Shankar, Rohini Vidya ; Agarwal, Shubhangi ; Stabenfeldt, Sarah E. ; ... More ▼

Description:

Cell therapy represents a promising therapeutic for a myriad of medical conditions, including cancer, traumatic brain injury, and cardiovascular disease among others. A thorough understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane core nanoemulsions as dual modality ((1)H MRI/Fluorescence), dual-functional (oximetry/detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a concentration of 10 μL/10(4) cells with a 40%v/v polydimethylsiloxane core nanoemulsion, doped with rhodamine, had minimal effect on viability, no effect on migration, proliferation and differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by (1)H MR and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling with a positive contrast (1)H MR probe has the potential to improve mechanistic knowledge of current therapies, and guide the design of future cell therapies due to its clinical translatability.

Subject:

[+]

Pubmed ID:

26597417

Pubmed Central ID:

PMC4792673

Document Type:

Journal Article

Funding:

DP2 HD084067/HD/NICHD NIH HHS/United States ; 1DP2HD084067/DP/NCCDPHP CDC HHS/United States ;

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

File Type:

Supporting Files:

	nihms740596f3.gif	image/gif
	nihms740596f3.jpg	image/jpeg
	nihms740596f4.gif	image/gif
	nihms740596f4.jpg	image/jpeg
	nihms740596f5.gif	image/gif
	nihms740596f5.jpg	image/jpeg
	nihms740596f6.gif	image/gif
	nihms740596f6.jpg	image/jpeg
	nihms740596f7.gif	image/gif
	nihms740596f7.jpg	image/jpeg
	NIHMS740596-supplement-10439_2015_1514_MOESM1_ESM.tif	image/tiff
	NIHMS740596-supplement-10439_2015_1514_MOESM2_ESM.tif	image/tiff
	NIHMS740596-supplement-10439_2015_1514_MOESM3_ESM.tif	image/tiff
	nihms740596.nxml	application/octet-stream
	nihms740596f1.gif	image/gif
	nihms740596f1.jpg	image/jpeg
	nihms740596f2.gif	image/gif
	nihms740596f2.jpg	image/jpeg

No Related Documents.

Siloxane nanoprobes for labeling and dual modality imaging of neural stem cells

Siloxane nanoprobes for labeling and dual modality imaging of neural stem cells

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC